(Q39947085)

15 September 2017

1 reference

title

Kidney disease and drug metabolism (English)

1 reference

15 September 2017

1 reference

Reidenberg MM

1

1 reference

15 September 2017

publication date

1 September 1974

1 reference

Medical Clinics of North America

15 September 2017

published in

1 reference

15 September 2017

volume

58

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

1059-1062

1 reference

The metabolic fate of vitamin D3-3H in chronic renal failure

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Histamine metabolism in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Guide to drug usage in adult patients with impaired renal function. A supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Isoniazid Dosage in Patients with Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Metabolism of free and conjugated 17-hydroxycorticosteroids in subjects with uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Clinical pharmacologic studies of L-asparaginase.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Diphenylhydantoin Metabolism in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

The influence of renal disease on the insulin I131 disappearance curve in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Pulmonary tuberculosis in patient on intermittent haemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Blood angiotensinase activity in relation to the breakdown of angiotensin II amide and nonisotopic phenylthiocarbamyl-angiotensin II amide in hypertensive and normotensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

The metabolism of phenacetin in patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

The rate of procaine hydrolysis in serum of normal subjects and diseased patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

Rate of drug metabolism in obese volunteers before and during starvation and in azotemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932101-0

7 January 2021

10.1016/S0025-7125(16)32101-0

Identifiers

DOI

0 references

1 reference